Search results

10 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
DeSimone talks about research, developing new medicines
Located in News / 2012 News
Grant will support study of nanomaterials to improve cancer drug delivery
A $2.4 million-grant from the National Institutes of Health will fund a collaborative research effort between UNC Lineberger Comprehensive Cancer Center and University of Nebraska Medical Center scientists. The researchers plan to study whether the use of a drug-carrying nanoparticle material they've designed can better penetrate tumors.
Located in News
Liquid Metal ‘Nano-Terminators’ Target Cancer Cells
The new cancer drug delivery system developed by the UNC School of Medicine and North Carolina State University improves efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.
Located in News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
UNC study shows potential for nanotechnology-based therapy for ovarian cancer
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
Located in News / 2011 News
UNC-Chapel Hill researchers to launch cancer nanotechnology training program
The university has received a grant from the National Institutes of Health to create a postdoctoral training program in cancer nanotechnology within the UNC Eshelman School of Pharmacy.
Located in News
UNC-Chapel Hill researchers awarded $11.3 million for cancer nanotechnology research
An $11.3 million, five-year grant from the National Cancer Institute will fund four studies by researchers with the Carolina Center of Cancer Nanotechnology Excellence.
Located in News
Wang published in ACS Nano
UNC Lineberger member Andrew Wang, MD, was senior author of a preclinical study published in the journal ACS Nano. Wang and collaborators found that they could improve cancer chemotherapy and chemoradiotherapy treatments by delivering a combination of cancer-fighting drugs using nanoparticles.
Located in Newsletters / / Honors and Awards / Honors and Awards - Old
Located in Newsroom / UNC Lineberger in the News